158
Participants
Start Date
November 30, 2005
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Pregabalin (Lyrica)
pregabalin 150mg/day (75mg BID)
Pregabalin (Lyrica)
pregabalin 300 mg/day (150mg BID)
Pregabalin (Lyrica)
pregabalin 600/day (300mg BID)
Placebo
Placebo
Pfizer Investigational Site, Calgary
Pfizer Investigational Site, Calgary
Pfizer Investigational Site, Calgary
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Red Deer
Pfizer Investigational Site, Kelowna
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Kingston
Pfizer Investigational Site, London
Pfizer Investigational Site, Port Hope
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Charlottetown
Pfizer Investigational Site, Granby
Pfizer Investigational Site, Laval
Pfizer Investigational Site, Laval
Pfizer Investigational Site, Lévis
Pfizer Investigational Site, Mirabel
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Sherbrooke
Pfizer Investigational Site, Sherbrook
Pfizer Investigational Site, Ste-Foy
Pfizer Investigational Site, Saskatoon
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY